Trademark Overview
On Wednesday, July 5, 2023, a trademark application was filed for NOVACUTAN with the United States Patent and Trademark Office. The USPTO has given the NOVACUTAN trademark a serial number of 79379230. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 2, 2024. This trademark is owned by Laboratoires Fijie. The NOVACUTAN trademark is filed in the Cosmetics & Cleaning Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
pharmaceutical preparations based on Botulinum toxin type A-hemagglutinin complex for treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; pharmaceutical preparations based on hyaluronic acid, namely for hypodermic injections, for treatment of arthrosis and for use in ophtalmic surgery; biological preparations for medical use for the treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; biological preparations for medical use for the treatment of arthrosis and for use in ophtalmic surgery; vitamin preparations; mineral supplements; albuminous multivitamin preparations for medical use
cosmetic products, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid for hypodermic injections
Medical services; cosmetology services, including beautician services and artist make-up services; hygienic care services for individuals; hairdressing services; manicure services; massage; advisory services in the field of cosmetic body and beauty care; advisory services concerning medical services; consultation with respect to pharmacy
medical products, including based on hyaluronic acid, namely dermal fillers, gel filler; implants, including surgical and medical implants, including those made from materials that are artificial, intradermal, intradermal based on hyaluronic acid or hyaluronic-acid-based materials, namely implants comprising natural, non-living materials; cannulae; surgical and medical apparatus and instruments, namely injection needles with round end points with lateral eyes; implantable devices, namely implantable drug delivery ports for the subcutaneous release of medicated substances; syringes for medical use; syringes for injections; hypodermic syringes
Research and development of new products, for others; biological research; scientific research services in the field of cosmetology